- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03170011
Biodex Sit2Stand for Individuals With Cardiac Disease
September 17, 2019 updated by: Michael Puthoff, St. Ambrose University
The Effects of the Biodex Sit2Stand Trainer on Function for Individuals With Cardiac Disease
Patients with cardiac disease have been shown to have deficits in activities such as standing up from a chair.
The Biodex Sit2Stand Trainer is a new device meant to improve sit to stand performance by providing a lifting force through the seat to help the individual stand.
The amount of lift can be graded to help improve leg strength, endurance, and function over time.
The device has the potential to be a form of training for those in cardiac rehabilitation who have limitations in standing from a chair.
Study Overview
Status
Withdrawn
Intervention / Treatment
Detailed Description
Patients who are diagnosed with cardiovascular disease and enter cardiac rehabilitation present with limitations in activity and restrictions in their abilities to participate in society.
Even after a standard course of cardiac rehabilitation, some individuals will still present with deficits.
One area this is seen is the ability to stand up from a chair.
A new device, the Biodex Sit2Stand Trainer, has been designed to help improve the standing movement in those with lower extremity weakness.
The trainer provides a graded lift or push through the seat to help the participant reach a standing posture.
This study will whether a six week training program using the trainer will lead to improvements in strength, function and quality of life for those individuals who have recently completed a cardiac rehabilitation program.
This study is a pilot study to help determine the ideal dosage of training and identify any limitations in using the device with this population.
Based on the results of this pilot work, a larger intervention study will be conducted to examine the effectiveness of the trainer in a cardiac rehabilitation program.
Study Type
Interventional
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 100 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Individuals nearing the end of their cardiac rehabilitation program will be asked to participate. Inclusion criteria include the following:
- Completion of a cardiac rehabilitation
- Ability to walk 50 feet independently with or without an assistive device
- Inability to stand from a standard chair five times without the use of their arms or unable to complete five sit to stands in less than 15 seconds.
- No major cardiac arrhythmias during cardiac rehabilitation sessions.
- Ability to attend 14 sessions over a 7-8 week period
Exclusion Criteria:
- Not meeting inclusion criteria
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
The training protocol will be include 12 sessions completed over six weeks following a periodization training format.
Each session will last approximately 40 minutes.
At first, training will focus on high volume, low intensity, self-selected velocity with a progression to high intensity, low volume, self-selected velocity ending with a focus on power training (moderate intensity, moderate volume, high velocity movement) over the six weeks of training.
|
Week 1-2 - Focused on lower intensity, higher volume, comfortable/self-selected velocity Week 3-4 - Focus on higher intensity, lower volume, comfortable/self-selected velocity Week 5 - Focus on moderate intensity, moderate volume, transitioning to higher velocity Week 6 - Focus on moderate intensity, moderate volume, high velocity
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Short Physical Performance Battery
Time Frame: Week 0 and Week 7
|
Lower extremity functional assessment tool which include gait speed, sit to stand ability and static balance
|
Week 0 and Week 7
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Isometric knee extension strength
Time Frame: Week 0 and Week 7
|
Measured in 90 degrees of flexion with hand held dynamometer
|
Week 0 and Week 7
|
|
Change in 10 meter gait speed
Time Frame: Week 0 and Week 7
|
Self selected walking speed over 10 meters
|
Week 0 and Week 7
|
|
Change in Six Minute Walk Test
Time Frame: Week 0 and Week 7
|
Total distance ambulated during a 6 minute time period.
|
Week 0 and Week 7
|
|
Change in HeartQoL
Time Frame: Week 0 and Week 7
|
Quality of Life assessment tool
|
Week 0 and Week 7
|
|
Change in MacNew
Time Frame: Week 0 and Week 7
|
Quality of life assessment tool
|
Week 0 and Week 7
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Jensen KH, Baekgaard N, Gaardsting O, Jelnes R, Tonnesen KH. [The social consequences of intermittent claudication]. Ugeskr Laeger. 1986 Oct 13;148(42):2715-7. No abstract available. Danish.
- Stevenson TG, Riggin K, Nagelkirk PR, Hargens TA, Strath SJ, Kaminsky LA. Physical activity habits of cardiac patients participating in an early outpatient rehabilitation program. J Cardiopulm Rehabil Prev. 2009 Sep-Oct;29(5):299-303. doi: 10.1097/HCR.0b013e3181b4ca61.
- Zullo MD, Dolansky MA, Jackson LW. Cardiac rehabilitation, health behaviors, and body mass index post-myocardial infarction. J Cardiopulm Rehabil Prev. 2010 Jan-Feb;30(1):28-34. doi: 10.1097/HCR.0b013e3181c8594b.
- Goel K, Shen J, Wolter AD, Beck KM, Leth SE, Thomas RJ, Squires RW, Perez-Terzic CM. Prevalence of musculoskeletal and balance disorders in patients enrolled in phase II cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2010 Jul-Aug;30(4):235-9. doi: 10.1097/HCR.0b013e3181e17387.
- Ades PA, Maloney A, Savage P, Carhart RL Jr. Determinants of physical functioning in coronary patients: response to cardiac rehabilitation. Arch Intern Med. 1999 Oct 25;159(19):2357-60. doi: 10.1001/archinte.159.19.2357.
- Puthoff ML, Youngs B. Cardiac Rehabilitation Leads to Improvements in Activity Limitations. J Cardiopulm Rehabil Prev. 2017 Nov;37(6):424-427. doi: 10.1097/HCR.0000000000000220.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
June 1, 2017
Primary Completion (Anticipated)
September 15, 2017
Study Completion (Anticipated)
September 15, 2017
Study Registration Dates
First Submitted
May 14, 2017
First Submitted That Met QC Criteria
May 26, 2017
First Posted (Actual)
May 30, 2017
Study Record Updates
Last Update Posted (Actual)
September 19, 2019
Last Update Submitted That Met QC Criteria
September 17, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1 (Other Identifier: Mobile Health and Wellness Program)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Infirmerie Protestante de LyonRecruitingCoronary Artery Bypass | Coronary Artery Disease(CAD) | Off Pump Coronary Artery Bypass Surgery | Hemodynamic Optimization | Hemodynamic Management | Off Pump Coronary Artery Bypass Graft | Coronary Artery Disease With Need for Bypass Surgery | NoradrenalineFrance
-
Shanghai Bluesail Boyuan Medical Technology Co....Not yet recruitingCoronary Artery Disease | Coronary Artery Calcification | Severe Coronary Artery DiseaseChina
-
Scitech Produtos Medicos SANot yet recruitingCoronary Artery Disease (CAD) | Multivessel Coronary Artery Disease | Complex Coronary Lesions | Calcific Coronary Arteriosclerosis | Small Vessel Ischemic Disease | Stenosis CoronaryBrazil
-
Istanbul Mehmet Akif Ersoy Educational and Training...Bakirkoy Dr. Sadi Konuk Research and Training Hospital; Ege University; Istanbul... and other collaboratorsActive, not recruitingCoronary Artery Disease (CAD) | Coronary Bifurcation Lesion | Left Main Coronary Artery StenosisTurkey (Türkiye)
-
I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioCompletedCoronary Artery Disease (CAD) | Atherosclerosis of Coronary ArteryItaly
-
EBI Anti Sepsis BVCR2O B.V.Not yet recruitingCoronary Artery Disease (CAD) | Coronary Artery Bypass Graft Surgery(CABG)United States, Netherlands, Belgium, United Kingdom
-
University Medical Centre LjubljanaRecruitingCoronary Artery Disease With Myocardial InfarctionSlovenia
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Shunmei MedicalNot yet recruitingCalcified Coronary Artery Disease | Coronary Arterial DiseasePoland, France, Spain
-
OPCI Core Laboratories LLCNot yet recruitingCoronary Artery Disease (CAD) | Coronary Calcification | Coronary Calcified Disease | Coronary Calcified NodulesUnited States
Clinical Trials on Exercise using the Biodex Sit2Stand Trainer
-
Giovanni TaveggiaCompletedDiabetic Neuropathies | Complications of Diabetes MellitusItaly
-
Kirsehir Ahi Evran UniversitesiRecruiting
-
Universidade do PortoNot yet recruitingLaparoscopic Surgical Training
-
Chen LiGansu Provincial Maternal and Child Health Care HospitalNot yet recruitingAutism Spectrum DisorderChina
-
University of Maryland, BaltimoreNational Institute on Aging (NIA)Completed
-
Kayseri City HospitalRecruitingAnkylosing SpondylitisTurkey
-
National and Kapodistrian University of AthensCompletedMenstrual Cycle | Exercise Performance ImpairmentGreece
-
Liverpool University Hospitals NHS Foundation TrustCompletedExercise-Induced Laryngeal ObstructionUnited Kingdom
-
University of MaltaEnrolling by invitationCoronary Artery Bypass | Cardiac DiseaseMalta
-
Rambam Health Care CampusThe Baruch Padeh Medical Center, PoriyaRecruitingCOVID-19 | MIS-C Associated With COVID-19Israel